Taiwan FDA registration 62d70d2e7d7fd8eaf34d6a4c05120833

"Critical" set of pushgi ST2 protein detection kits

TW: “關鍵”普司吉ST2蛋白檢測試劑組
Taiwan flagTaiwan·Risk Class 2·CRITICAL CARE DIAGNOSTICS, INC.;; BIOCHECK, INC.·Registered Sep 11, 2014 – Sep 11, 2019Cancelled
Registration details
Analysis ID
62d70d2e7d7fd8eaf34d6a4c05120833
Customs Code
DHA05602652607
Company information
Manufacturer Country
United States
Authorized Representative
HEALTH ONE NETWORK CO., LTD.
Product details
Intended Use
Enzyme-linked immunoassay (ELISA) technology was used to quantitatively detect ST2 protein in human serum or plasma.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1660 Quality control materials (analytical and non-analytical); A.1117 Type B diuretic lithium peptide test system
Import Information
Contract manufacturing;; input
Dates and status
Registration Date
Sep 11, 2014
Expiry Date
Sep 11, 2019
Cancellation Date
Jun 22, 2022
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for "Critical" set of pushgi ST2 protein detection kits in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 62d70d2e7d7fd8eaf34d6a4c05120833 and manufactured by CRITICAL CARE DIAGNOSTICS, INC.;; BIOCHECK, INC.. The authorized representative in Taiwan is HEALTH ONE NETWORK CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices